---
stable_id: R-HSA-9664933
display_name: Phosphorylated heterodimers of ERBB2 KD mutants and EGFR, in complex
  with GRB2:GAB1, bind PI3K
species: Homo sapiens
summary: 'For the following EGFR-binding ERBB2 KD mutants that activate PI3K/AKT signaling,
  it is assumed that, like the wild type ERBB2:EGFR heterodimer, binding to the GRB2:GAB1
  adaptor complex leads to recruitment of the PI3K complex: <br><br>ERBB2 L755S (Kancha
  et al. 2011, Cocco et al. 2018, Croessmann et al. 2019);<br>ERBB2 L755P (Kancha
  et al. 2011);<br>ERBB2 I767M (Ng et al. 2015; heterodimerization with EGFR indirectly
  shown by Bose et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011);<br>ERBB2 G778_P780dup
  (Suzawa et al. 2016);<br>ERBB2 T798M (Kancha et al. 2011, Rexer et al. 2013);<br>ERBB2
  T798I (Hanker et al. 2017);<br>ERBB2 T862A (Kancha et al. 2011);<br>ERBB2 H878Y
  (Kancha et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 Y772_A775dup
  (Wang et al. 2006);<br><br>Activation of PI3K/AKT signaling downstream of the following
  ERBB2 KD cancer mutants has not been studied and they are annotated as candidates:<br><br>ERBB2
  L755M<br>ERBB2 L755W<br>ERBB2 V777M<br>ERBB2 V777E<br>ERBB2 T733I<br>ERBB2 H878R'
---

# Phosphorylated heterodimers of ERBB2 KD mutants and EGFR, in complex with GRB2:GAB1, bind PI3K
**Reactome ID:** [R-HSA-9664933](https://reactome.org/content/detail/R-HSA-9664933)
**Species:** Homo sapiens

## Summary

For the following EGFR-binding ERBB2 KD mutants that activate PI3K/AKT signaling, it is assumed that, like the wild type ERBB2:EGFR heterodimer, binding to the GRB2:GAB1 adaptor complex leads to recruitment of the PI3K complex: <br><br>ERBB2 L755S (Kancha et al. 2011, Cocco et al. 2018, Croessmann et al. 2019);<br>ERBB2 L755P (Kancha et al. 2011);<br>ERBB2 I767M (Ng et al. 2015; heterodimerization with EGFR indirectly shown by Bose et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011);<br>ERBB2 G778_P780dup (Suzawa et al. 2016);<br>ERBB2 T798M (Kancha et al. 2011, Rexer et al. 2013);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 T862A (Kancha et al. 2011);<br>ERBB2 H878Y (Kancha et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 Y772_A775dup (Wang et al. 2006);<br><br>Activation of PI3K/AKT signaling downstream of the following ERBB2 KD cancer mutants has not been studied and they are annotated as candidates:<br><br>ERBB2 L755M<br>ERBB2 L755W<br>ERBB2 V777M<br>ERBB2 V777E<br>ERBB2 T733I<br>ERBB2 H878R
